FDA Inspection 1041315 — Nostrum Laboratories, Inc.
The FDA completed an inspection of Nostrum Laboratories, Inc. on Jan 11, 2018 in Bryan, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 11, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bryan, OH (United States)